Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
What to do after breast cancer develops resistance to endocrine therapy? Elacestrant significantly improves progression-free survival. 07/06/2022 breast cancer ESR1
